Fibroblast growth factor-21 (FGF-21) is a novel metabolically active hormone that has been investigated, given its potential therapeutic role in obesity and metabolic recovery following bariatric surgery, particularly for diabetes. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.